The Incidence and Risk Analysis of Lung Cancer Development in Patients with Chronic Obstructive Pulmonary Disease: Possible Effectiveness of Annual CT-Screening

References

• World Health Organization. The top 10 causes of death; 24 May 2018. Available from: http://who.int/mediacentre/factsheets/fs310/en/. Accessed May 3, 2020.
   Google Scholar
• MacNee W. Pathology, pathogenesis, and pathophysiology. BMJ. 2006;332(7551):1202–1204. doi:10.1136/bmj.332.7551.1202
   Web of Science ®Google Scholar
• Bradford E, Jacobson S, Varasteh J, et al. The value of blood cytokines and chemokines in assessing COPD. Respir Res. 2017;18(1):180. doi:10.1186/s12931-017-0662-2
   PubMedGoogle Scholar
• Sin DD, Anthonisen NR, Soriano JB, Agust AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257. doi:10.1183/09031936.00133805
   PubMed Web of Science ®Google Scholar
• Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34(2):380–386. doi:10.1183/09031936.00144208
   PubMed Web of Science ®Google Scholar
• Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data from the First National Health and Nutrition examination survey follow-up. Arch Intern Med. 2003;163(12):1475–1480. doi:10.1001/archinte.163.12.1475
   PubMedGoogle Scholar
• Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med. 1986;105(4):503–507. doi:10.7326/0003-4819-105-4-503
   PubMed Web of Science ®Google Scholar
• de Torres JP, Marín JM, Casanova C, et al. Lung cancer in patients with chronic obstructive pulmonary disease– incidence and predicting factors. Am J Respir Crit Care Med. 2011;184(8):913–919. doi:10.1164/rccm.201103-0430OC
   PubMed Web of Science ®Google Scholar
• Chubachi S, Takahashi S, Tsutsumi A, et al. Radiologic features of precancerous areas of the lungs in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017;12:1613–1624.
   PubMed Web of Science ®Google Scholar
• Haruna A, Muro S, Nakano Y, et al. CT scan findings of emphysema predict mortality in COPD. Chest. 2010;138(3):635–640. doi:10.1378/chest.09-2836
   PubMed Web of Science ®Google Scholar
• Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871–888. doi:10.2147/COPD.S49621
   PubMed Web of Science ®Google Scholar
• Vilkman S, Keistinen T, Tuuponen T, Kivelä SL. Survival and cause of death among elderly chronic obstructive pulmonary disease patients after first admission to hospital. Respiration. 1997;64(4):281–284. doi:10.1159/000196687
   PubMed Web of Science ®Google Scholar
• Bale G, Martínez-Camblor P, Burge PS, Soriano JB. Long-term mortality follow-up of the ISOLDE participants: causes of death during 13 years after trial completion. Respir Med. 2008;102(10):1468–1472. doi:10.1016/j.rmed.2008.04.001
   PubMed Web of Science ®Google Scholar
• Jenkins CR, Jones PW, Calverley PM, et al. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res. 2009;10(1):59. doi:10.1186/1465-9921-10-59
   PubMedGoogle Scholar
• Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE; Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142(4):233–239. doi:10.7326/0003-4819-142-4-200502150-00005
   PubMed Web of Science ®Google Scholar
• Shibata Y, Inoue S, Igarashi A, et al. A lower level of forced expiratory volume in 1 second is a risk factor for all-cause and cardiovascular mortality in a Japanese population: the Takahata study. PLoS One. 2003;8(12):e83725. doi:10.1371/journal.pone.0083725
   Web of Science ®Google Scholar
• de Torres JP, Bastarrika G, Wisnivesky JP, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest. 2007;132(6):1932–1938. doi:10.1378/chest.07-1490
   PubMed Web of Science ®Google Scholar
• Wilson DO, Weissfeld JL, Balkan A, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med. 2008;178(7):738–744. doi:10.1164/rccm.200803-435OC
   PubMed Web of Science ®Google Scholar
• Wasswa-Kintu S, Gan WO, Man SFP, Pare PD, Sin DD. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax. 2005;60(7):570–575. doi:10.1136/thx.2004.037135
   PubMed Web of Science ®Google Scholar
• Zulueta JJ, Wisnivesky JP, Henschke CI, et al. Emphysema scores predict death from COPD and lung cancer. Chest. 2012;141(5):1216–1223. doi:10.1378/chest.11-0101
   PubMed Web of Science ®Google Scholar
• Sandelin M, Mindus S, Thuresson M, et al. Factors associated with lung cancer in COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:1833–1839.
   PubMed Web of Science ®Google Scholar
• Raymakers AJN, Sadatsafavi M, Sin DD, FitzGerald JM, Marra CA, Lynd LD. Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study. Eur Respir J. 2019;53(6):1801257. doi:10.1183/13993003.01257-2018
   PubMed Web of Science ®Google Scholar
• The Japanese Respiratory Society. [Guidelines for the management of asthma and COPD overlap]. Tokyo: Medical Review; 2018. Japanese.
   Google Scholar
• Ishii A, Sugiyama H, Kirikae T, et al. Correlations between computed tomography images and respiratory function in chronic obstructive pulmonary disease. AJRS. 2014;3(2):221–226.
   Google Scholar
• The Japan Lung Cancer Society. [General rule for clinical and pathological record of lung cancer]. Tokyo: KANEHARA & CO; 2017. Japanese.
   Google Scholar
• Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27(17):2758–2765. doi:10.1200/JCO.2008.20.8983
   PubMed Web of Science ®Google Scholar
• Santillan AA, Camargo CA Jr, Colditz GA. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control. 2003;14(4):327–334. doi:10.1023/A:1023982402137
   PubMed Web of Science ®Google Scholar
• Gorlova OY, Zhang Y, Schabath MB, Lei L, Zhang Q, Amos CI. Never smokers and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer. 2006;118(7):1798–1804. doi:10.1002/ijc.21561
   PubMed Web of Science ®Google Scholar
• El-Zein M, Parent ME, Kâ K, Siemiatycki J, St-Pierre Y, Rousseau MC. History of asthma or eczema and cancer risk among men: a population-based case-control study in Montreal, Quebec, Canada. Ann Allergy Asthma Immunol. 2010;104(5):378–384. doi:10.1016/j.anai.2010.03.003
   PubMed Web of Science ®Google Scholar
• Ramanakumar AV, Parent ME, Menzies D, Siemiatycki J. Risk of lung cancer following nonmalignant respiratory conditions: evidence from two case-control studies in Montreal, Canada. Lung Cancer. 2006;53(1):5–12. doi:10.1016/j.lungcan.2006.04.007
   PubMed Web of Science ®Google Scholar
• Parimon T, Chien JW, Bryson CL, McDonell MB, Udris EM, Au DH. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175(7):712–719. doi:10.1164/rccm.200608-1125OC
   PubMed Web of Science ®Google Scholar
• Papi A, Casoni G, Caramori G, et al. COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax. 2004;59(8):679–681. doi:10.1136/thx.2003.018291
   PubMed Web of Science ®Google Scholar
• Roviello G, Zanotti L, Cappelletti MR, et al. Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer? Clin Exp Med. 2018;18(1):15–20. doi:10.1007/s10238-017-0460-7
   PubMed Web of Science ®Google Scholar
• Fathi Z, Syn NL, Zhou JG, Roudi R. Molecular epidemiology of lung cancer in Iran: implications for drug development and cancer prevention. J Hum Genet. 2018;63(7):783–794. doi:10.1038/s10038-018-0450-y
   PubMed Web of Science ®Google Scholar